PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
NCT04517864
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
71
Enrollment
INDUSTRY
Sponsor class
Stopped
For business reasons
Conditions
Alopecia Areata
Interventions
DRUG:
PF-06651600
DRUG:
Placebo
Sponsor
Pfizer